[A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide]. [PDF]
Probl Endokrinol (Mosk)Troshina EA +7 more
europepmc +1 more source
[Fulminant hypercorticism due to ACTG producing pheochromocytoma]. [PDF]
Probl Endokrinol (Mosk), 2023 Useinova ZT +11 more
europepmc +1 more source
[Pituitary disorders in patients with end-stage chronic renal failure]. [PDF]
Probl Endokrinol (Mosk)Markova TN, Kosova EV, Mishchenko NK.
europepmc +1 more source
[Validation and testing of the Russian version of PHPQoL questionnaire for quality of life assessment in patients with primary hyperparathyroidism (PHPT)]. [PDF]
Probl Endokrinol (Mosk), 2021 Gladkova IN +6 more
europepmc +1 more source
Does everyone need to take vitamin D? High prevalence of CYP24A1 deficiency in the Russian population. [PDF]
Probl Endokrinol (Mosk)Kulikova KS +14 more
europepmc +1 more source
[Experience in using teriparatide for the treatment of postoperative hypoparathyroidism in hemodialysis patients]. [PDF]
Probl Endokrinol (Mosk), 2022 Eremkina AK +4 more
europepmc +1 more source
[Van Wyk-Grombach syndrome as a result of late diagnosis of autoimmune thyroiditis (ait) in a patient with chromosome 22 deletion syndrome. Description of the clinical case and a brief review of the literature]. [PDF]
Probl Endokrinol (Mosk)Momotova AA +3 more
europepmc +1 more source
[Congenital hypopituitarism with monosomy of chromosome 18]. [PDF]
Probl Endokrinol (Mosk), 2021 Bolmasova AV +5 more
europepmc +1 more source
[Switching patients from cinacalcet to etelcalcetide: evaluation of predictors of efficacy in a retrospective cohort study]. [PDF]
Probl Endokrinol (Mosk)Parshina EV +3 more
europepmc +1 more source
[Dynamics the parameters of mineral metabolism in hospitalized patients with COVID-19, the impact of etiotropic and pathogenetic therapy]. [PDF]
Probl Endokrinol (Mosk), 2023 Maganeva IS +8 more
europepmc +1 more source